Skip to main content

Wednesday: Put Pens to the Paper, Write a Letter to the Editor in Support of Research

Submitted by dguard on

[Courtesy of ASA]

Dear ASA Supporter,

This week, ASA called on you to "Join the Movement" and “Meet Your Senators.” Today, we are asking you to take your involvement to the next level by making your voice heard and putting your pens to the paper for medical cannabis research. Write a letter to the editor about medical cannabis to educate your community about the issues patients and doctors face every day.

 

Write a letter to the editor of your local newspaper calling on your Senators to support access for FDA-approved medical marijuana research. FDA-approved research is key to safe access nationwide. Use the talking points provided as a guide, but please be sure to personalize your message. Editors do not appreciate receiving several of the same messages so be sure to make yours unique!

Please write a letter to the editor today about the importance of medical cannabis research and how your Senators can get involved. Read on for ways to take action.

Ways to Make Your Voice Heard:

1. Use ASA's LTE Action Page to write a letter to the editor about research: After clicking here you will be asked pick your state, then you can choose from newspapers in your area, and finally you will be taken to a page with talking points, but please personalize your letter. Editors do not appreciate receiving several of the same messages so be sure to make yours unique!

 

2. Join the Movement: In the past day, hundreds of supporters have joined the movement by donating to ASA. There are thousands more of you who support ASA, but have not taken action yet. Please join the movement today. It only takes a couple minutes and will renew your commitment to the medical cannabis movement.

3. Spread the Word: Forward this message widely to friends, co-workers, and family to encourage them to join you in the national movement to protect safe access!

 

Sincerely,

Kris Hermes
Media Specialist
Americans for Safe Access

Permission to Reprint: This content is licensed under a modified Creative Commons Attribution license. Content of a purely educational nature in Drug War Chronicle appear courtesy of DRCNet Foundation, unless otherwise noted.